摘要:
The present invention relates to a pharmaceutical or veterinary composition for the use thereof in preventing and/or treating infection by the influenza viruses. Said composition is characterized in that it contains, in an appropriate pharmaceutical carrier, at least one compound selected from among Etilefrine and Diltiazem.
摘要:
The invention relates to an in vitro or ex vivo method for assessing the risk of complication in patients who have suffered an attack or infection resulting in systemic inflammatory response syndrome. The invention is characterized in that it comprises the step of detecting, in a biospecimen collected from said patient, at least one transcript of the IL7R gene, as well as the use of assaying, in vitro or ex vivo , the amount of at least one transcript of the IL7R gene, in a biospecimen collected from a patient who has suffered an attack or infection resulting in systemic inflammatory response syndrome, to assess the risk of complication, and in particular mortality, in said patient. The invention also relates to kits for assaying, in vitro or ex vivo , the amount of at least one transcript of the IL7R gene in a biospecimen.
摘要:
The invention relates to pharmaceutical or veterinary compositions for preventing or treating viral infections and, in particular, for preventing or treating infections by the influenza A, B and C viruses.